Form 8-K - Current report:
SEC Accession No. 0001493152-24-050448
Filing Date
2024-12-17
Accepted
2024-12-17 17:23:00
Documents
17
Period of Report
2024-12-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 43232
2 ex10-1.htm EX-10.1 94694
3 ex99-1.htm EX-99.1 10689
  Complete submission text file 0001493152-24-050448.txt   397824

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE bfrg-20241212.xsd EX-101.SCH 3718
5 XBRL DEFINITION FILE bfrg-20241212_def.xml EX-101.DEF 29945
6 XBRL LABEL FILE bfrg-20241212_lab.xml EX-101.LAB 36511
7 XBRL PRESENTATION FILE bfrg-20241212_pre.xml EX-101.PRE 26968
20 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5646
Mailing Address 325 ELLINGTON BLVD. UNIT 317 GAITHERSBURG MD 20878
Business Address 325 ELLINGTON BLVD. UNIT 317 GAITHERSBURG MD 20878 3013672055
BullFrog AI Holdings, Inc. (Filer) CIK: 0001829247 (see all company filings)

EIN.: 844786155 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41600 | Film No.: 241556784
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)